Malayao, Yves Doreen .
HRN: 21-09-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2023
METRONIDAZOLE 500MG (TAB)
06/20/2023
06/27/2023
PO
500mg
TID
Thickly Meconium Stained Amniotic Fluid
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes